Montenarh, D; Hopf, M; Warth, S; Maurer, HH; Schmidt, P; Ewald, AH. A simple extraction and LC-MS/MS approach for the screening and identification of over 100 analytes in eight different matrices: Detection of 130 analytes in eight biosamples using only one LC-MS/MS method. Drug Test. Anal., 1 Mar 2015, 7 (3), 214-240. 593 kB. https://doi.org/10.1002/dta.1657
Currie, KS. Antianxiety Agents. In Burger's Medicinal Chemistry and Drug Discovery; Abraham, DJ, Ed., John Wiley & Sons, Inc., 15 Jan 2003; pp 525–597. 2.7 MB. https://doi.org/10.1002/0471266949.bmc102 #1
Hudkins, RL; Marino, MJ; Williams, M. Cognition. In Burger's Medicinal Chemistry and Drug Discovery; Abraham, DJ, Ed., John Wiley & Sons, Inc., 29 Jan 2010; pp 15–60. 784 kB. https://doi.org/10.1002/0471266949.bmc242 #94
Chambers, SA; DeSousa, JM; Huseman, ED; Townsend, SD. The DARK side of total synthesis: Strategies and tactics in psychoactive drug production. ACS Chem. Neurosci., 17 Oct 2018, 9 (10), 2307–2330. 8.1 MB. https://doi.org/10.1021/acschemneuro.7b00528 #101
Cappelli, A; Anzini, M; Castriconi, F; Grisci, G; Paolino, M; Braile, C; Biggio, G. Design, synthesis, and biological evaluation of imidazo[1,5-a]quinoline as highly potent ligands of central benzodiazepine receptors. J. Med. Chem., 14 Apr 2016, 59 (7), 3353–3372. 3.0 MB. https://doi.org/10.1021/acs.jmedchem.6b00034 #1 MS,NMR
Huang, Q; He, X; Ma, C; Liu, R; Yu, S; Dayer, CA; Wenger, GR; McKernan, R; Cook, JM. Pharmacophore/receptor models for GABAA/BzR subtypes (α1β3γ2, α5β3γ2, and α6β3γ2) via a comprehensive ligand-mapping approach. J. Med. Chem., 1 Jan 2000, 43 (1), 71–95. 912 kB. https://doi.org/10.1021/jm990341r #145
Clayton, T. Part I. Unified pharmacophore protein models of the benzodiazepine receptor subtypes. Part II. Subtype selective ligands for α5 GABA(A)/BZ receptors. Ph. D. Thesis, University of Wisconsin-Milwaukee, 1 Dec 2012. 28.1 MB. #Diazepam
Noggle, FT; Clark, CR. Identification of some benzodiazepines of forensic interest. J. Assoc. Off. Anal. Chem., , 62 (4), 799–807. 259 kB. #7 LC,IR,UV
Antonides, LH; Brignall, RM; Costello, A; Ellison, J; Firth, SE; Gilbert, N; Groom, BJ; Hudson, SJ; Hulme, MC; Marron, J; Pullen, ZA; Robertson, TBR; Schofield, CJ; Williamson, DC; Kemsley, EK; Sutcliffe, OB; Mewis, RE. Rapid identification of novel psychoactive and other controlled substances using low-field 1H NMR spectroscopy. ACS Omega, 30 Apr 2019, 4 (4), 7103–7112. 1.3 MB. https://doi.org/10.1021/acsomega.9b00302 #Diazepam NMR
Angenoorth, TJF; Stankovic, S; Niello, M; Holy, M; Brandt, SD; Sitte, HH; Maier, J. Interaction profiles of central nervous system active drugs at human organic cation transporters 1–3 and human plasma membrane monoamine transporter. Int. J. Mol. Sci., 30 Nov 2021, 22 (23), 12995. 5.1 MB. https://doi.org/10.3390/ijms222312995 #Diazepam
Angelos, SA; Janovsky, TJ; Raney, JK. The identification and quantitation of pharmaceutical preparations by nuclear magnetic resonance spectroscopy. J. Forensic Sci., 1 Mar 1991, 36 (2), 358–365. 383 kB. https://doi.org/10.1520/JFS13038J #Diazepam NMR
Sarwar, M; Taylor, S; Majeed, I. A specific screening color test for diazepam. Microgram J., 1 Jul 2008, 6 (3–4), 63–71. 678 kB. #Diazepam spot